Literature DB >> 12788038

Effect of levetiracetam in refractory childhood epilepsy syndromes.

L Lagae1, G Buyse, A Deconinck, B Ceulemans.   

Abstract

In this open-label add-on study of levetiracetam in refractory childhood epilepsy syndromes, we studied the effect of a rapid introduction of levetiracetam on the total seizure frequency in 21 children, known to have partial and generalized seizures. Starting dosage was 10 mg/kg/day, increased every 4th day by 10 mg/kg up to a maximum of 60 mg/kg/day, depending on efficacy and tolerability. In this highly refractory population, 47% showed a seizure frequency reduction of more than 50%. Levetiracetam was effective both in partial and generalized seizures, with a significant effect on myoclonic seizures. Only mild side-effects were observed in four of 21 children, at a dosage of more than 40 mg/kg/day.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788038     DOI: 10.1016/s1090-3798(03)00041-2

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  13 in total

1.  A new generation of anticonvulsants for the treatment of epilepsy in children.

Authors:  O Carter Snead; Elizabeth J Donner
Journal:  Paediatr Child Health       Date:  2007-11       Impact factor: 2.253

Review 2.  Levetiracetam in childhood epilepsy.

Authors:  Alberto Verrotti; Ebe D'Adamo; Pasquale Parisi; Francesco Chiarelli; Paolo Curatolo
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

Review 3.  Benefit-risk assessment of levetiracetam in the treatment of partial seizures.

Authors:  Bassel Abou-Khalil
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Efficacy and safety of levetiracetam in pediatric epilepsy.

Authors:  Ahmed A Elberry; Rawabi K Felemban; Rawan H Hareeri; Sawsan M Kurdi
Journal:  Saudi Pharm J       Date:  2011-06-15       Impact factor: 4.330

Review 5.  Use of second-generation antiepileptic drugs in the pediatric population.

Authors:  Allison M Chung; Lea S Eiland
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 6.  Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.

Authors:  Anand Iyer; Richard Appleton
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.022

Review 7.  New generation anticonvulsants for the treatment of epilepsy in children.

Authors:  Elizabeth J Donner; O Carter Snead
Journal:  NeuroRx       Date:  2006-04

8.  Current trends in the treatment of infantile spasms.

Authors:  Chang-Yong Tsao
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

9.  Levetiracetam in the treatment of childhood epilepsy.

Authors:  James W Wheless
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

10.  Levetiracetam in the treatment of epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.